What changed from existing technology?
This study found that certain cells in brain tumors help turn blood cells into immune cells that support tumor growth.
This is the first study to show that FAP+ pericyte-like cells directly influence the differentiation of monocytes into tumor-associated macrophages in glioblastoma.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This finding may help develop new strategies to target the tumor immune microenvironment in glioblastoma treatment.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.